vimarsana.com

Latest Breaking News On - Medios group - Page 1 : vimarsana.com

Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year guidance

EQS-News: Medios AG / Key word: Quarterly / Interim Statement/Quarter Results Medios AG records further revenue growth in the first quarter of 2024 and confirms full-year.

Claudia nickolausMatthias gaertnerGoldman sachsMedios groupCeban pharmaceuticalsbvSpecialty pharma solutionsCeban pharmaceuticalsSpecialty pharmaPharmaceutical supplyPatient specific therapiesBlister gmbhChief executive officerEuropean specialty pharmaSpecific therapiesWarburg highlightsHalf year financial report

Medios AG: achieves further growth in the first half of 2023 and expects strong third quarter

EQS-News: Medios AG / Key word(s): Half Year Report/Half Year ResultsMedios AG: achieves further growth in the first half of 2023 and expects strong third quarter 14.08.2023 / 07:53 CET/CESTThe issuer is solely responsible for the content of this announcement.Press releaseMedios AG achieves further growth in the fir.

Comunidad autonoma de catalunaFrance generalBlisterzentrum badenFalk neukirchClaudia nickolausMatthias gaertnerSpecialty pharma solutionsMarket solutions forumMedios groupDistribution servicesJefferies fireside chat series back to schoolGoldman sachsHalf yearHalf year resultsBlisterzentrum baden wBlister gmbh

EQS-News: Medios AG: achieves further growth in the first half of 2023 and expects strong third quarter

EQS-News: Medios AG: achieves further growth in the first half of 2023 and expects strong third quarter
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

France generalComunidad autonoma de catalunaBlisterzentrum badenFalk neukirchClaudia nickolausMatthias gaertnerMedios groupJefferies fireside chat series back to schoolGoldman sachsSpecialty pharma solutionsMarket solutions forum parisBlisterzentrum baden wBlister gmbhPharmaceutical supplyPatient specific therapiesSupervisory board

Kepler Capital Sticks to Their Buy Rating for Medios AG (MEDOF)

Kepler Capital analyst Allegre Ludovic maintained a Buy rating on Medios AG (MEDOF – Research Report) on May 28. The company’s shar.

Allegre ludovicWarburg researchMedios groupResearch report onKepler capitalResearch reportStrong buyMedicinal productsPatient specific therapies

Kepler Capital Remains a Buy on Medios AG (MEDOF)

Kepler Capital analyst Allegre Ludovic maintained a Buy rating on Medios AG (MEDOF – Research Report) on March 30 and set a price target .

Allegre ludovicResearch report onMedios groupKepler capitalResearch reportModerate buyMedicinal productsPatient specific therapies

vimarsana © 2020. All Rights Reserved.